<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab1">
 <label>Table 1</label>
 <caption>
  <p>Various studies addressing the impact of waiting time/TTI on cancer survival/prognosis</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>Author, year [Ref]</th>
    <th>No of patients</th>
    <th>Malignancy</th>
    <th>Time to surgery</th>
    <th>Salient features</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>Kristian et al. 2020 [
     <xref ref-type="bibr" rid="CR14">14</xref>]
    </td>
    <td>–</td>
    <td>Urinary bladder</td>
    <td>–</td>
    <td>Delay in cystectomy by &gt; 90 days for MIBC increases pN+ rate, decreases OS, DFS and higher pathologic stage</td>
   </tr>
   <tr>
    <td>Furukawa et al. 2019 [
     <xref ref-type="bibr" rid="CR15">15</xref>]
    </td>
    <td>696</td>
    <td>Stomach</td>
    <td>Up to 90 days</td>
    <td>Preoperative wait time up to 90 days does not affect survival in patients with stage II/III gastric cancer.</td>
   </tr>
   <tr>
    <td>Visser et al. 2016 [
     <xref ref-type="bibr" rid="CR16">16</xref>]
    </td>
    <td>351</td>
    <td>Oesophagus</td>
    <td>8 weeks versus &gt; 8 weeks</td>
    <td>Post NACT-Surgery within 8 weeks or beyond 8 weeks has no impact on DFS or OS.</td>
   </tr>
   <tr>
    <td>Bleicher et al. 2015 [
     <xref ref-type="bibr" rid="CR17">17</xref>]
    </td>
    <td>94,544</td>
    <td>Breast</td>
    <td>&lt; 30 versus &gt; 30 days</td>
    <td>Significant difference in DFS and OS in early breast cancer.</td>
   </tr>
   <tr>
    <td>Shin et al. 2013 [
     <xref ref-type="bibr" rid="CR18">18</xref>]
    </td>
    <td>7529</td>
    <td>Colorectal, breast, thyroid, lung</td>
    <td>12 weeks</td>
    <td>More than 12 weeks’ delay is associated with increased mortality in colorectal, breast but not thyroid/lung cancers.</td>
   </tr>
   <tr>
    <td>Fossati et al. 2017 [
     <xref ref-type="bibr" rid="CR19">19</xref>]
    </td>
    <td>2653</td>
    <td>Prostate</td>
    <td>12 months</td>
    <td>Surgical treatment can be postponed up to 12 months.</td>
   </tr>
   <tr>
    <td>Khorana et al. 2019 [
     <xref ref-type="bibr" rid="CR20">20</xref>]
    </td>
    <td>3,672,561</td>
    <td>Pancreas, lung, breast, kidney, colorectal</td>
    <td>Median TTI-27 days</td>
    <td>Increased TTI is associated with absolute increased risk of mortality in early-stage breast, lung, renal and pancreas cancers.</td>
   </tr>
   <tr>
    <td>Murphy et al. 2016 [
     <xref ref-type="bibr" rid="CR21">21</xref>]
    </td>
    <td>51,655</td>
    <td>Head neck</td>
    <td>&lt; 30 days versus 60–90 days</td>
    <td>Increased mortality beyond 46–52 days, detrimental beyond 60 days.</td>
   </tr>
   <tr>
    <td>Dolly et al. 2016 [
     <xref ref-type="bibr" rid="CR22">22</xref>]
    </td>
    <td>889</td>
    <td>Endometrium</td>
    <td>Mean 48 days</td>
    <td>Decreased survival with increased delay</td>
   </tr>
   <tr>
    <td>Jeon et al. 2017 [
     <xref ref-type="bibr" rid="CR23">23</xref>]
    </td>
    <td>2863</td>
    <td>PTC</td>
    <td>&lt; 12 versus &gt; 12 months</td>
    <td>No difference in recurrence/disease free survival</td>
   </tr>
   <tr>
    <td>Froehner et al. 2016 [
     <xref ref-type="bibr" rid="CR24">24</xref>]
    </td>
    <td>1</td>
    <td>Kidney</td>
    <td>30 days</td>
    <td>Rapid increase in the level of tumour thrombus with delay</td>
   </tr>
   <tr>
    <td>Waldert et al. 2009 [
     <xref ref-type="bibr" rid="CR25">25</xref>]
    </td>
    <td>187</td>
    <td>UTUC</td>
    <td>&lt; 3 versus &gt; 3 months</td>
    <td>Delay to surgery is associated with disease progression but not with mortality or recurrence.</td>
   </tr>
   <tr>
    <td>Baudin et al. 2015 [
     <xref ref-type="bibr" rid="CR26">26</xref>]
    </td>
    <td>–</td>
    <td>Adrenal</td>
    <td>–</td>
    <td>ACC progresses rapidly and delay may decrease resectability and affect survival.</td>
   </tr>
   <tr>
    <td>Kabir et al. 2020 [
     <xref ref-type="bibr" rid="CR27">27</xref>]
    </td>
    <td>863</td>
    <td>HCC</td>
    <td>&lt; 30 versus &gt; 30 days</td>
    <td>Time to surgery does not affect OS.</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <p>
   <italic>TTI</italic> time to treatment initiation, 
   <italic>NACT</italic> neoadjuvant chemotherapy, 
   <italic>DFS</italic> disease-free survival, 
   <italic>OS</italic> overall survival, 
   <italic>PTC</italic> papillary thyroid cancer, 
   <italic>UTUC</italic> upper urothelial tract urothelial carcinoma, 
   <italic>MIBC</italic> muscle invasive bladder cancer, 
   <italic>HCC</italic> hepatocellular carcinoma, 
   <italic>ACC</italic> adrenocortical carcinoma
  </p>
 </table-wrap-foot>
</table-wrap>
